F. Hoffmann-La Roche AG vs United Airlines Holdings, Inc.: Strategic Comparison
Key Differences at a Glance
| Field | F. Hoffmann-La Roche AG | United Airlines Holdings, Inc. |
|---|---|---|
| Revenue | $77.2B | $59.1B |
| Founded | 1896 | 1926 |
| Employees | 112,774 | 113,200 |
| Market Cap | $327.5B | $38.2B |
| Headquarters | Switzerland | United States |
Quick Stats Comparison
| Metric | F. Hoffmann-La Roche AG | United Airlines Holdings, Inc. |
|---|---|---|
| Revenue | $77.2B | $59.1B |
| Founded | 1896 | 1926 |
| Headquarters | Basel, Switzerland | Chicago, Illinois |
| Market Cap | $327.5B | $38.2B |
| Employees | 112,774 | 113,200 |
F. Hoffmann-La Roche AG Revenue vs United Airlines Holdings, Inc. Revenue — Year by Year
| Year | F. Hoffmann-La Roche AG | United Airlines Holdings, Inc. | Leader |
|---|---|---|---|
| 2025 | $77.2B | $59.1B | F. Hoffmann-La Roche AG |
| 2024 | $75.9B | $57.1B | F. Hoffmann-La Roche AG |
| 2023 | $75.9B | $53.7B | F. Hoffmann-La Roche AG |
Business Model Breakdown
Overview: F. Hoffmann-La Roche AG vs United Airlines Holdings, Inc.
This in-depth comparison examines F. Hoffmann-La Roche AG and United Airlines Holdings, Inc. across revenue, market value, business model, competitive positioning, and long-term growth strategy. Whether you are researching F. Hoffmann-La Roche AG on its own, evaluating United Airlines Holdings, Inc., or weighing the two companies side by side, the breakdown below highlights where each company leads and where the gap between F. Hoffmann-La Roche AG and United Airlines Holdings, Inc. is widest.
On the headline numbers, F. Hoffmann-La Roche AG reports annual revenue of $77.2B against $59.1B for United Airlines Holdings, Inc., while their respective market capitalizations stand at $327.5B and $38.2B. F. Hoffmann-La Roche AG is headquartered in Switzerland and United Airlines Holdings, Inc. operates from United States, and those different home markets shape how each company competes.
F. Hoffmann-La Roche AG: Roche is not just a drug company with a diagnostics side business. Its strategic identity is an integrated healthcare model: test the patient, identify the biology, treat with a targeted therapy, and use outcome data to improve the next development cycle.
United Airlines Holdings, Inc.: A network airline is a coordination machine. United's value comes from putting the right aircraft, crew, schedules, airport slots, loyalty incentives, and corporate contracts together so thousands of connecting markets become sellable every day.
Business Models: How F. Hoffmann-La Roche AG and United Airlines Holdings, Inc. Make Money
F. Hoffmann-La Roche AG and United Airlines Holdings, Inc. pursue distinct approaches to generating revenue, and understanding how each company operates is the foundation of any fair comparison between F. Hoffmann-La Roche AG and United Airlines Holdings, Inc..
F. Hoffmann-La Roche AG business model: Roche makes money from branded prescription medicines, biologics, oncology and specialty drugs, diagnostic instruments, diagnostic reagents, sequencing and molecular testing, diabetes care products, and clinical data assets. Pharmaceuticals drive the largest share of sales, while Diagnostics adds recurring reagent revenue and supports personalized healthcare.
United Airlines Holdings, Inc. business model: United makes money from passenger tickets, premium cabins, basic economy, cargo, MileagePlus loyalty economics, co-branded credit card revenue, baggage and seat fees, United Club memberships, and partner revenue. Hubs create network density that lets the airline fill aircraft and price global itineraries.
Competitive Advantage: F. Hoffmann-La Roche AG vs United Airlines Holdings, Inc.
The durability of a company's moat often decides long-term winners. Here is how the competitive advantages of F. Hoffmann-La Roche AG stack up against those of United Airlines Holdings, Inc..
F. Hoffmann-La Roche AG competitive advantage: Roche's advantage is the combination of drug development, diagnostics, Genentech biotechnology depth, companion diagnostic capability, and oncology data assets from Foundation Medicine and Flatiron Health. Competitors can match pieces of this model, but few can connect medicines, tests, and real-world data at similar scale.
United Airlines Holdings, Inc. competitive advantage: United's advantage is its hub network, international route breadth, Star Alliance connectivity, premium-cabin expansion, MileagePlus loyalty base, corporate account strength, and major positions at airports such as Chicago O'Hare, Newark, Denver, Houston, San Francisco, Washington Dulles, and Los Angeles.
Growth Strategy: Where F. Hoffmann-La Roche AG and United Airlines Holdings, Inc. Are Headed
Future prospects matter as much as current results. The growth strategies below explain how F. Hoffmann-La Roche AG and United Airlines Holdings, Inc. each plan to expand from here.
F. Hoffmann-La Roche AG growth strategy: Roche is investing in late-stage medicines, diagnostics platforms, sequencing, companion diagnostics, real-world evidence, and selective acquisitions that strengthen oncology, immunology, neuroscience, and cardiovascular-metabolic disease areas.
United Airlines Holdings, Inc. growth strategy: United is investing in premium seating, larger aircraft, international routes, operational reliability, MileagePlus, airport clubs, digital service, Starlink connectivity, and network depth at core hubs.
Financial Picture: F. Hoffmann-La Roche AG vs United Airlines Holdings, Inc.
A closer look at the financial trajectory of F. Hoffmann-La Roche AG and United Airlines Holdings, Inc. rounds out the comparison.
F. Hoffmann-La Roche AG: Roche reported CHF 61.5 billion in 2025 group sales. Pharmaceuticals sales were CHF 47.7 billion and Diagnostics sales were CHF 13.8 billion. Core operating profit was CHF 21.8 billion, and R&D core investments were CHF 12.2 billion. For USD comparability, this profile converts CHF 61.5 billion at 1 CHF = 1.25506 USD.
United Airlines Holdings, Inc.: United's 2025 total operating revenue was USD 59.1 billion, up 3.5%. Operating income was USD 4.7 billion. Passenger revenue rose 3.1% as passengers increased 4.3% and capacity increased 6.1%, while other operating revenue grew 10.4% helped by loyalty and club revenue.
Company-Specific SWOT Notes
F. Hoffmann-La Roche AG
Roche's advantage is the combination of drug development, diagnostics, Genentech biotechnology depth, companion diagnostic capability, and oncology data assets from Foundation Medicine and Flatiron Health.
Roche wins by combining medicines, diagnostics, biomarkers, and oncology data into a precision-healthcare model competitors struggle to copy.
The biggest risk is that biosimilar erosion and pricing pressure outrun the replacement power of Roche new launches and late-stage pipeline.
Roche is investing in late-stage medicines, diagnostics platforms, sequencing, companion diagnostics, real-world evidence, and selective acquisitions that strengthen oncology, immunology, neuroscience, and cardiovascular-metabolic disease areas.
United Airlines Holdings, Inc.
United's advantage is its hub network, international route breadth, Star Alliance connectivity, premium-cabin expansion, MileagePlus loyalty base, corporate account strength, and major positions at airports such as Chicago O'Hare, Newark, Denver, Houston, San Francisco, Washington Dulles, and Los Angeles.
United wins when its hubs, international routes, loyalty program, and premium seats make it the most convenient and valuable airline for high-frequency travelers.
The biggest risk is cost pressure from fuel, labor, aircraft delays, or disruption that outpaces fare and loyalty revenue growth.
United is investing in premium seating, larger aircraft, international routes, operational reliability, MileagePlus, airport clubs, digital service, Starlink connectivity, and network depth at core hubs.
Head-to-Head Scorecard
| Category | Winner | Why |
|---|---|---|
| Revenue Scale | F. Hoffmann-La Roche AG | F. Hoffmann-La Roche AG reports the larger revenue base ($77.2B), which serves as a core operational scale signal. |
| Profitability Potential | Comparable | Both organizations prioritize market penetration or are at equivalent reporting tiers. |
| Company Age | F. Hoffmann-La Roche AG | Founded in 1896 vs 1926. The earlier pioneer typically commands longer historical institutional legacy. |
| Innovation Moat | F. Hoffmann-La Roche AG | Higher aggregate count of major acquisitions and key R&D releases indicates a more active technology absorption velocity. |
| Scale (Employees) | United Airlines Holdings, Inc. | A significantly larger reported workforce supports enhanced global distribution capability. |
| Market Cap | F. Hoffmann-La Roche AG | Higher public valuation denotes greater forward-looking investor conviction in earnings potential. |
| Future Outlook | Tied | Strategic auditing assesses that both maintain defensive leadership vectors within their core market clusters. |
Who Wins Each Category?
F. Hoffmann-La Roche AG reports the larger revenue base ($77.2B), which serves as a core operational scale signal.
Both organizations prioritize market penetration or are at equivalent reporting tiers.
Founded in 1896 vs 1926. The earlier pioneer typically commands longer historical institutional legacy.
Higher aggregate count of major acquisitions and key R&D releases indicates a more active technology absorption velocity.
A significantly larger reported workforce supports enhanced global distribution capability.
Who Wins: F. Hoffmann-La Roche AG or United Airlines Holdings, Inc.?
Reviewed by Swet Parvadiya, May 2026 - Author Profile
Our analysts compile business strategy profiles from public financial filings, press releases, and analyst reports. Each profile is reviewed for accuracy before publication by our editorial desk and updated on a rolling basis.
Frequently Asked Questions: F. Hoffmann-La Roche AG vs United Airlines Holdings, Inc.
Is F. Hoffmann-La Roche AG better than United Airlines Holdings, Inc.?
Verdict: Between F. Hoffmann-La Roche AG and United Airlines Holdings, Inc., F. Hoffmann-La Roche AG is the stronger overall option based on higher annual revenue. The decision still depends on which factors matter most for your needs, but on the weight of the evidence above, F. Hoffmann-La Roche AG comes out ahead in this F. Hoffmann-La Roche AG vs United Airlines Holdings, Inc. comparison.
Who earns more — F. Hoffmann-La Roche AG or United Airlines Holdings, Inc.?
F. Hoffmann-La Roche AG earns more with $77.2B in annual revenue versus United Airlines Holdings, Inc.'s $59.1B. F. Hoffmann-La Roche AG leads on total revenue based on latest verified figures.
Which company has higher revenue — F. Hoffmann-La Roche AG or United Airlines Holdings, Inc.?
F. Hoffmann-La Roche AG reported $77.2B, while United Airlines Holdings, Inc. reported $59.1B. The revenue leader is F. Hoffmann-La Roche AG based on latest verified figures.
F. Hoffmann-La Roche AG revenue vs United Airlines Holdings, Inc. revenue — which is higher?
F. Hoffmann-La Roche AG revenue: $77.2B. United Airlines Holdings, Inc. revenue: $59.1B. F. Hoffmann-La Roche AG has the larger revenue base of the two companies.
Sources & References
- F. Hoffmann-La Roche AG Corporate Website
- F. Hoffmann-La Roche AG Annual Report 2025 - Revenue and Financial Data
- roche.com
- roche.com
- assets.roche.com
- roche.com
- stockanalysis.com
- ofx.com
- SEC EDGAR: United Airlines Holdings, Inc. Annual Filings (10-K, 8-K)
- United Airlines Holdings, Inc. Corporate Website
- United Airlines Holdings, Inc. Annual Report 2025 - Revenue and Financial Data
- sec.gov
- united.com
- ir.united.com